Saturday, December 14, 2019

Bias, Corruption & Accountability

Pervasive Industry Influence in Healthcare Sector Harms Patients

Experts across the globe point to the harms of drug companies’ influence on research, practice, and education in healthcare noting that it compromises patient care.

Statisticians: Current Policies Approve Ineffective Treatments

Current standards for clinical trials rely on statistical methods that allow for ineffective treatments to gain approval.

Researchers Address Dangers of Polypharmacy and Inappropriate Medication Use

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

D-Cycloserine Supplement Does Not Add Much to Exposure Therapy

A closer look at a new study reporting that the supplement D-cycloserine improved anxiety when used with exposure therapy.

Despite Claims, EPA Supplement Does Not Improve ADHD Symptoms in Youth

A new study reports that the supplement EPA improved ADHD symptoms but a closer look calls these results into question.

Textbooks Provide Misleading Information on the Neurobiology of ADHD

When it comes to ADHD, some researchers suggest that medical textbooks provide inaccurate and misleading information.

NICE Guideline Update Acknowledges Severe Antidepressant Withdrawal

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

“Flimsy Evidence” for Esketamine as Depression Treatment

A new article documents the “flimsy evidence” behind the recent FDA approval of the party drug esketamine for the treatment of depression.

Researchers: “Antidepressants Should Not be Used for Adults with Major Depressive Disorder”

A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.

Zoloft Does Not Improve Depression, Even in Severe Cases, Study Finds

Despite their finding, the researchers suggest that SSRIs be given to people who do not meet criteria for depression or anxiety.

Guidelines Recommending Antidepressants “in Contradiction with the Current Evidence”

Researchers critique the German S3 guidelines for depression promoting antidepressants.

Substantial Spin Found in Leading Psychology and Psychiatry Journals

: A new review finds evidence of spin and the misrepresentation of clinical trials with non-significant results.

Review Finds FDA Approval of Digital Antipsychotic Misguided

The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.

Positive Antidepressant Study “Misleading” and “Erroneous”

An analysis of last year’s positive finding in The Lancet about antidepressant efficacy shows errors, obfuscations, and misrepresentations.

Getting Pharma Out of Medical Education: An Interview with Dr. Adriane Fugh-Berman

MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.

Mad Science, Psychiatric Coercion and the Therapeutic State: An Interview with Dr. David Cohen

MIA's Peter Simons interviews David Cohen, PhD, on his path to researching mental health, coercive practices, and discontinuation from psychiatric drugs.

Mobile Apps for Mental Health Lack Transparency in Data Sharing

Research illustrates privacy concerns with how mental health applications collect and share users’ data.

Fighting for the Meaning of Madness: An Interview with Dr. John Read

Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.

Study Reveals Inconsistency in ADHD Diagnostic Determinations

Researchers compare differences between research and clinical diagnoses of ADHD and explore the consistency of clinical determinations over time

Researchers Find Bias in Industry-Funded Continuing Medical Education

Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.

Researchers Fail to Replicate Evidence for “Biotypes” of Depression

A new study casts doubt on whether such biotypes for depression exist.

Antidepressant Use Linked to Longer, More Frequent Psychiatric Rehospitalization

New study finds that antidepressants may negatively impact recovery after psychiatric hospitalization.

The Impact of Regression to the Mean in Psychiatric Drug Studies

Could the statistical phenomenon of regression to the mean be responsible for the dramatic effects of placebo—as well as the supposed effectiveness of some psychiatric drugs?

Withdrawal Symptoms Routinely Confound Findings of Psychiatric Drug Studies

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

Psychiatrists View Drug-Free Programs for Psychosis as “Unscientific,” Study Finds

A new study provides an insider’s look into how psychiatrists view the establishment of drug-free programs in Norway.

Follow Us

19,639FansLike
11,994FollowersFollow
3,560SubscribersSubscribe